Strategies to Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies
In a series of 3 patient simulation cases, learn how the more durable anti-VEGF agents, aflibercept 8 mg and faricimab, can be used to treat neovascular AMD
Related Articles
Harrow launches Harrow Cares program in partnership with Cencora
The program will deliver a range of high-quality access and affordability services for retina specialists.
Intracranial pressure levels may be a critical factor in glaucoma
KOLOA, Hawaii — Intracranial pressure may be just as critical of a factor in the progression of glaucoma as IOP, according to a speaker here…
Annual Meeting
The Annual Meeting is the premier U.S. meeting dedicated to anterior segment surgery with tailored education and unmatched inspirational opportunities. In 2024—the 50 th anniversary…
Rising Stars in Retina: Lauren Kiryakoza, MD – Retina Today
Retina Today: When did you first know that you wanted to become a retina specialist? My exposure to retina was serendipitous. I applied for an…
Glaucoma Basics & FAQs
Learn about Glaucoma, Glaucoma signs and symptoms, and how to prevent blindness from Gluacoma
Ophthalmic Complications Associated With Semaglutide and Tirzepatide
This case series reports ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide.
Ophthalmic Professional January – 2025
STAFF’S GUIDE TO MIGS P. 7 THE LATEST IN GLAUCOMA DIAGNOSTICS P. 9 JANUARY 2025 OphthalmicProfessional.com Dr. Sahar Bedrood, and her team of technicians and…
VIDEO: Macular telangiectasia type 2 cell therapy shows promising 9-year data
KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Mark Gillies, MD, PhD, of the Save Sight Institute in Sydney, Australia, discusses positive…
The Ophthalmologist Power List 2025: Nominate Now!
Nominate your candidate for The Ophthalmologist Power List, which celebrates the most inspiring and influential in the eye care industry
Apellis Pharmaceuticals receives approval of pegcetacoplan (Syfovre) for treatment of geographic atrophy in Australia
The approval of Syfovre makes it the first and only approved treatment for GA in Australia.